GeneDx Holdings Corp. Increase (Decrease) in Other Current Liabilities
GeneDx Holdings Corp. (WGS) reported Increase (Decrease) in Other Current Liabilities of -$5.62 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2023-08-08
- GeneDx Holdings Corp. increase (decrease) in other current liabilities for the quarter ending 2023-06-30 was $2.14M, a 20.54% increase year-over-year.
- GeneDx Holdings Corp. increase (decrease) in other current liabilities for the quarter ending 2023-03-31 was -$7.76M.
- GeneDx Holdings Corp. increase (decrease) in other current liabilities for the quarter ending 2022-12-31 was -$9.46M, a 243.01% decline year-over-year.
- GeneDx Holdings Corp. increase (decrease) in other current liabilities for the quarter ending 2022-09-30 was -$5.20M, a 216.90% decline year-over-year.
- GeneDx Holdings Corp. increase (decrease) in other current liabilities for fiscal 2022 was -$19.47M, a 701.02% decline from fiscal 2021.
- GeneDx Holdings Corp. increase (decrease) in other current liabilities for fiscal 2021 was $3.24M, a 79.71% decline from fiscal 2020.
- GeneDx Holdings Corp. increase (decrease) in other current liabilities for fiscal 2020 was $15.96M, a 258.57% increase from fiscal 2019.
- GeneDx Holdings Corp. increase (decrease) in other current liabilities for fiscal 2019 was $4.45M.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|---|---|
| 2023-06-30 | $2.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$5.62M 10-Q · filed 2023-08-08 | -$15.08M derived: sum of 3 quarters · filed 2023-08-08 | -$20.28M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | -$7.76M 10-Q · filed 2023-05-09 | -$17.22M derived: sum of 2 quarters · filed 2023-05-09 | -$22.42M derived: sum of 3 quarters · filed 2023-05-09 | -$20.64M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | -$9.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$14.66M derived: sum of 2 quarters · filed 2023-03-16 | -$12.88M derived: sum of 3 quarters · filed 2023-08-08 | -$19.47M 10-K · filed 2023-03-16 |
| 2022-09-30 | -$5.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$3.42M derived: sum of 2 quarters · filed 2023-08-08 | -$10.01M 10-Q · filed 2022-11-14 | -$3.39M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-06-30 | $1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$4.81M 10-Q · filed 2023-08-08 | $1.81M derived: sum of 3 quarters · filed 2023-08-08 | $6.26M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$6.58M 10-Q · filed 2023-05-09 | $30.00K derived: sum of 2 quarters · filed 2023-05-09 | $4.48M derived: sum of 3 quarters · filed 2023-05-09 | $5.80M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $6.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $11.06M derived: sum of 2 quarters · filed 2023-03-16 | $12.39M derived: sum of 3 quarters · filed 2023-03-16 | $3.24M 10-K · filed 2023-03-16 |
| 2021-09-30 | $4.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $5.77M derived: sum of 2 quarters · filed 2022-11-14 | -$3.38M 10-Q · filed 2022-11-14 | $2.52M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $1.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$7.82M 10-Q · filed 2022-08-15 | -$1.93M derived: sum of 3 quarters · filed 2023-03-16 | |
| 2021-03-31 | -$9.15M 10-Q · filed 2022-05-12 | -$3.26M derived: sum of 2 quarters · filed 2023-03-16 | ||
| 2020-12-31 | $5.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $15.96M 10-K · filed 2023-03-16 | ||
| 2020-09-30 | $10.07M 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | $4.45M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |